All growth rates are year-on-year between FY2025 and FY2024. • Revenue of $659.7 million (ZAR 12.0 billion) up 14% in ZAR. • Net Revenue (a non-GAAP measure) of $328.7 million (ZAR 5.3 billion), up 38 ...

JOHANNESBURG, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the fourth quarter (“Q4 2025”) and full year of fiscal 2025 (“FY2025”).

Rather than building a fresh customer base from scratch, the strategy was to extend services to the next generation within households already engaged with the bank. This significantly reduced ...

JOHANNESBURG, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the fourth quarter (“Q4 2025”) and full year of fiscal 2025 (“FY2025”).

Fischer announced, "Utilizing this revised measure of adjusted EBITDA, IDT expects to generate a range of $141 million to $145 million in consolidated adjusted EBITDA for fiscal '26." This represents ...

Gross profit increased 30% year-over-year to $1.9 million for H1 2025, compared to $1.5 million for the same period last year Gross margin increased 450 basis points to 31.5% for H1 2025, compared to ...

INLIF LIMITED (Nasdaq: INLF) (the Company or INLIF), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced i ...

Stronger antitrust enforcement is necessary to prevent reduced access to reproductive health care, including abortion, birth control, and fertility treatments, while safeguarding market competition.